Identification and Confirmation of Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement and Characterization of Treatment Patterns and Outcomes in a Real-World Setting: A US Retrospective Chart Review
This study highlights the importance of cytogenetic and molecular evaluations in patients with chronic/blast phase hematologic malignancies to diagnose MLN-FGFR1. This is particularly important following US approval of pemigatinib for this hematologic malignancy.
Authors
- Shreekant Parasuraman (ORCID: https://orcid.org/0000-0001-8162-8171)
- Philomena Colucci
- Kim Saverno (ORCID: https://orcid.org/0000-0002-3421-3755)
- Kristin Zimmerman Savill
Institutions
- Cardinal Health (United States) (US)
- Incyte (United States) (US)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2025-07-05
- DOI
- https://doi.org/10.1159/000546910
- Primary Topic
- Eosinophilic Disorders and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Incyte